PRNewswire

NEW YORK, May 22, 2024 /PRNewswire/ — Perseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of infla

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: